The bladder cancer experts at Duke Prostate and Urologic Cancer Center bring you today's cutting-edge treatments to help you reach a healthier tomorrow. Our specialists are leaders in the diagnosis and treatment of bladder cancer as members of Duke’s nationally ranked urology and cancer programs.
The Duke Prostate and Urologic Cancer Center is a collaborative powerhouse, using the latest leading-edge medical, surgical and radiation therapies to provide comprehensive and personalized care. As a top referral center for bladder cancer, we specialize in hard-to-find and difficult-to-treat cases.
Ready for an appointment? Please visit Duke Health.
Finding bladder cancer early and getting an accurate diagnosis is key to your health and overall outcome. Here are some tests your oncologist may order:
The Duke Prostate and Urologic Cancer Center bladder cancer specialists use the latest medical and surgical advances to treat bladder cancer at every stage, including non-invasive, invasive and metastatic disease. Sophisticated techniques target treatment of your bladder tumor while minimizing disruption to healthy tissue. If needed, our skilled surgeons can perform complex surgery and reconstruction suited to individual patient circumstances and preferences.
The following are some of the treatment options available:
Surgery for cancer removal:
These procedures form a urinary diversion (reservoir to store and excrete urine) after your bladder is removed during a radical cystectomy. Duke offers three options:
Our patients also have access to an enhanced recovery program— one of only a handful of such centers in the United States — that adheres to guidelines to keep you healthier and get you back to the comfort of home sooner after major surgery. This program is designed to reduce your in-hospital time and lessen the chance for complications by promoting early feeding and physical activity while maximizing pain control using a multimodal approach that reduces the need for opioids.
We personalize your treatment plan and care to your specific form of bladder cancer. Our strategy ensures that you receive the most effective treatments available. Our urologic, radiation and medical oncologists work together with ostomy and specialty nursing and psychologists to carefully monitor your cancer and design a comprehensive treatment plan.
Because each patient’s cancer possesses unique characteristics that allow for a diversity of behaviors and outcomes, we take a personalized approach to determining the best therapies for each patient.
As part of a precision medicine approach, we may utilize patient-specific urine, blood or tissue-based genetic tests to help inform treatment decisions.
Clinical research is critical to our collective mission of reducing the burden of bladder cancer by designing better treatments and preventive approaches. Duke clinicians and researchers are involved in ongoing projects to individually tailor therapies to a patient's unique characteristics, including clinical, social, cultural, ethnic and genetic factors.
Our collective Duke team lead the way in ground-breaking bladder cancer research. For example, our physician-scientists were the first to identify and examine the role of PD-L1 in bladder cancer and its association with adverse outcomes. This provided the basis for the new immunotherapy agents that exist today. We also led the first clinical trials of two novel treatments using heat to treat non-invasive bladder cancer.
Committed to changing the rules on cancer, our bladder cancer specialists are leading national research efforts while breaking down traditional barriers to rapid innovation and novel treatments.
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.Ways To Give